FDA.reportPublic FDA data

momelotinib 200 MG Oral Tablet [Ojjaara]

RxCUI
2665224
RxNorm name
momelotinib 200 MG Oral Tablet [Ojjaara]
Display name
momelotinib 200 MG Oral Tablet [Ojjaara]
Full name
momelotinib 200 MG Oral Tablet [Ojjaara]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4a672fd1-eb7b-4aa9-9b23-845e4b5dc400momelotinib 200 MG Oral Tablet [Ojjaara]SBD8These highlights do not include all the information needed to use OJJAARA safely and effectively. See full prescribing information for OJJAARA. OJJAARA (momelotinib) tablets, for oral use Initial U.S. Approval: 202320260513
4a672fd1-eb7b-4aa9-9b23-845e4b5dc400Ojjaara 200 MG Oral TabletPSN8These highlights do not include all the information needed to use OJJAARA safely and effectively. See full prescribing information for OJJAARA. OJJAARA (momelotinib) tablets, for oral use Initial U.S. Approval: 202320260513
4a672fd1-eb7b-4aa9-9b23-845e4b5dc400Ojjaara 200 MG (equivalent to 243.88 MG momelotinib dihydrochloride monohydrate) Oral TabletSY8These highlights do not include all the information needed to use OJJAARA safely and effectively. See full prescribing information for OJJAARA. OJJAARA (momelotinib) tablets, for oral use Initial U.S. Approval: 202320260513